EVOME MEDICAL TECHNOLOGIES INC. Quarterly Liabilities in CAD from Q1 2021 to Q4 2023

Taxonomy & unit
us-gaap: CAD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Evome Medical Technologies Inc. quarterly Liabilities history and growth rate from Q1 2021 to Q4 2023.
  • Evome Medical Technologies Inc. Liabilities for the quarter ending December 31, 2023 was CA$44.3M, a 20.5% increase year-over-year.
Liabilities, Quarterly (CAD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 44.3M +7.54M +20.5% Dec 31, 2023 10-K 2024-04-16
Q3 2023 48.5M +16.6M +52.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 54.3M +33.6M +162% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 38.9M +9.41M +31.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 36.7M +1.94M +5.57% Dec 31, 2022 10-K 2024-04-16
Q3 2022 31.9M +8.27M +35% Aug 31, 2022 10-Q 2022-10-17
Q2 2022 20.7M -3.08M -12.9% May 31, 2022 10-Q 2022-07-15
Q1 2022 29.5M +23M +355% Feb 28, 2022 10-KT 2023-04-03
Q4 2021 34.8M Dec 31, 2021 10-KT 2023-04-03
Q3 2021 23.6M Aug 31, 2021 10-Q 2021-10-15
Q2 2021 23.8M May 31, 2021 10-Q/A 2021-08-02
Q1 2021 6.49M Feb 28, 2021 10-K 2022-05-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.